Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents

American Journal of Cardiology

Volumn 104, Issue 9, 2009, Pages 1229-1234

  van Kuijk, Jan Peter ^a   Flu, Willem Jan ^a   Schouten, Olaf ^a   Hoeks, Sanne E ^a   Schenkeveld, Lisanne ^a   de Jaegere, Peter P T ^a   Bax, Jeroen J ^a   van Domburg, Ron T ^b   Serruys, Patrick W ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PACLITAXEL; PROTON PUMP INHIBITOR; RAPAMYCIN;

ABDOMINAL SURGERY; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BETA ADRENERGIC RECEPTOR BLOCKING; BLEEDING; CANCER SURGERY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DATA BASE; DRUG ELUTING STENT; EAR NOSE THROAT SURGERY; EMERGENCY SURGERY; ESTHETIC SURGERY; EYE SURGERY; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; NONCARDIAC SURGERY; NOSE SURGERY; ORAL SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; STENT THROMBOSIS; SURGICAL RISK; SURGICAL TECHNIQUE; VASCULAR SURGERY;

CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETREATMENT; STENTS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 71849088447     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.038     Document Type: Article

References (23)

1. Vicenzi M.N., Ribitsch D., Luha O., Klein W., and Metzler H. Coronary artery stenting before noncardiac surgery: more threat than safety?. Anesthesiology 94 (2001) 367-368
2. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., Freeman W.K., Froehlich J.B., Kasper E.K., Kersten J.R., Riegel B., Robb J.F., Smith Jr. S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Buller C.E., Creager M.A., Ettinger S.M., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Lytle B.W., Nishimura R., Ornato J.P., Page R.L., Riegel B., Tarkington L.G., and Yancy C.W. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50 (2007) e159-e241
3. Grines C.L., Bonow R.O., Casey Jr. D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., and Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a Science Advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49 (2007) 734-739
4. Rabbitts J.A., Nuttall G.A., Brown M.J., Hanson A.C., Oliver W.C., Holmes D.R., and Rihal C.S. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 109 (2008) 596-604
5. Lemos P.A., Lee C.H., Degertekin M., Saia F., Tanabe K., Arampatzis C.A., Hoye A., van Duuren M., Sianos G., Smits P.C., de Feyter P., van der Giessen W.J., van Domburg R.T., and Serruys P.W. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 41 (2003) 2093-2099
6. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., Fleisher L.A., Froehlich J.B., Gusberg R.J., Leppo J.A., Ryan T., Schlant R.C., Winters Jr. W.L., Gibbons R.J., Antman E.M., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Jacobs A.K., Hiratzka L.F., Russell R.O., and Smith Jr. S.C. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac Surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 94 (2002) 1052-1064
7. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
8. Anand S., Yusuf S., Xie C., Pogue J., Eikelboom J., Budaj A., Sussex B., Liu L., Guzman R., Cina C., Crowell R., Keltai M., and Gosselin G. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 (2007) 217-227
9. Nuttall G.A., Brown M.J., Stombaugh J.W., Michon P.B., Hathaway M.F., Lindeen K.C., Hanson A.C., Schroeder D.R., Oliver W.C., Holmes D.R., and Rihal C.S. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 109 (2008) 588-595
10. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., Pichard A.D., Satler L.F., Waksman R., and Serruys P.W. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
11. Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., and Kolodgie F.D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
12. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
13. Leibowitz D., Cohen M., Planer D., Mosseri M., Rott D., Lotan C., and Weiss A.T. Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stenting. Am J Cardiol 97 (2006) 1188-1191
14. Reddy P.R., and Vaitkus P.T. Risks of noncardiac surgery after coronary stenting. Am J Cardiol 95 (2005) 755-757
15. Wilson S.H., Fasseas P., Orford J.L., Lennon R.J., Horlocker T., Charnoff N.E., Melby S., and Berger P.B. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 (2003) 234-240
16. Honda Y., and Fitzgerald P.J. Stent thrombosis: an issue revisited in a changing world. Circulation 108 (2003) 2-5
17. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., and Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
18. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., Peterson E.D., Schulman K.A., and Califf R.M. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
19. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., and Kaiser C. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
20. Schouten O., van Domburg R.T., Bax J.J., de Jaegere P.J., Dunkelgrun M., Feringa H.H., Hoeks S.E., and Poldermans D. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 49 (2007) 122-124
21. Harder S., Klinkhardt U., et al. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 43 (2004) 963-981
22. Burger W., Chemnitius J.M., Kneissl G.D., and Rucker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 257 (2005) 399-414
23. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502